Fonollosa-Pla V - Search Results

1

Novel risk factors related to cancer in scleroderma.

Bernal-Bello D, de Tena JG, Guillén-Del Castillo A, Selva-O'Callaghan A, Callejas-Moraga EL, Marín-Sánchez AM, Fonollosa-Pla V, Simeón-Aznar CP. Bernal-Bello D, et al. Autoimmun Rev. 2017 May;16(5):461-468. doi: 10.1016/j.autrev.2017.03.012. Epub 2017 Mar 8. Autoimmun Rev. 2017. PMID: 28285170 Review.

2

Thrombotic thrombocytopenic purpura preceding systemic lupus erythematosus.

Simeon-Aznar CP, Cuenca-Luque R, Fonollosa-Pla V, Bosch-Gil JA. Simeon-Aznar CP, et al. Ann Rheum Dis. 1992 Mar;51(3):396-8. doi: 10.1136/ard.51.3.396. Ann Rheum Dis. 1992. PMID: 1575591 Free PMC article.

3

Lack of evidence of foetal microchimerism in female Spanish patients with systemic sclerosis.

Selva-O'Callaghan A, Mijares-Boeckh-Behrens T, Prades EB, Solans-Laqué R, Simeón-Aznar CP, Fonollosa-Pla V, Vilardell-Tarrés M. Selva-O'Callaghan A, et al. Lupus. 2003;12(1):15-20. doi: 10.1191/0961203303lu248oa. Lupus. 2003. PMID: 12587821

4

[Scleroderma].

Fonollosa Pla V, Simeón Aznar CP. Fonollosa Pla V, et al. Med Clin (Barc). 2004 Mar 27;122(11):418-9. doi: 10.1016/s0025-7753(04)74258-x. Med Clin (Barc). 2004. PMID: 15066250 Spanish. No abstract available.

5

Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.

Solans-Laqué R, Pérez-Bocanegra C, Salud-Salvia A, Fonollosa-Plá V, Rodrigo MJ, Armadans L, Simeón-Aznar CP, Vilardell-Tarres M. Solans-Laqué R, et al. Lupus. 2004;13(3):159-64. doi: 10.1191/0961203304lu521oa. Lupus. 2004. PMID: 15119543

6

Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis.

Balada E, Simeón-Aznar CP, Serrano-Acedo S, Martínez-Lostao L, Selva-O'Callaghan A, Fonollosa-Pla V, Vilardell-Tarrés M. Balada E, et al. Clin Exp Rheumatol. 2006 May-Jun;24(3):321-4. Clin Exp Rheumatol. 2006. PMID: 16870103

7

Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis.

Balada E, Simeón-Aznar CP, Ordi-Ros J, Rosa-Leyva M, Selva-O'Callaghan A, Pardos-Gea J, Fonollosa-Pla V, Vilardell-Tarrés M. Balada E, et al. Ann Rheum Dis. 2008 Jul;67(7):1027-9. doi: 10.1136/ard.2007.085480. Epub 2008 Feb 13. Ann Rheum Dis. 2008. PMID: 18272670

8

Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term study.

Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Selva-O Callaghan A, Solans-Laqué R, Palliza E, Muñoz X, Vilardell-Tarrés M. Simeón-Aznar CP, et al. Open Respir Med J. 2008;2:39-45. doi: 10.2174/1874306400802010039. Epub 2008 May 15. Open Respir Med J. 2008. PMID: 19340324 Free PMC article.

9

[Clinical features and prognosis of patients with scleroderma renal crisis].

Roda-Safont A, Simeón-Aznar CP, Fonollosa-Plà V, Segarra-Medrano A, Vilardell-Tarrés M. Roda-Safont A, et al. Med Clin (Barc). 2011 Oct 15;137(10):431-4. doi: 10.1016/j.medcli.2011.03.014. Epub 2011 May 18. Med Clin (Barc). 2011. PMID: 21596402 Spanish.

10

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease.

Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Selva-O'Callaghan A, Solans-Laqué R, Vilardell-Tarrés M. Simeón-Aznar CP, et al. Clin Rheumatol. 2011 Nov;30(11):1393-8. doi: 10.1007/s10067-011-1823-1. Epub 2011 Sep 1. Clin Rheumatol. 2011. PMID: 21881859 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page